# Treatment Of Patients With Social Anxiety Disorder

> **NCT00397722** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 299 (actual)

## Conditions studied

- Social Phobia

## Interventions

- **DRUG:** GW876008
- **DRUG:** paroxetine

## Key facts

- **NCT ID:** NCT00397722
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11-09
- **Primary completion:** 2007-09-05
- **Final completion:** 2007-09-05
- **Target enrollment:** 299 (ACTUAL)
- **Last updated:** 2017-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00397722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00397722, "Treatment Of Patients With Social Anxiety Disorder". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00397722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*